Democrats Blast HHS For Flu Antiviral Production Shortcomings
This article was originally published in The Pink Sheet Daily
Executive Summary
Democratic members of the House Government Reform Committee question why HHS Secretary Leavitt has not issue a compulsory license to allow other manufacturers to produce Roche's Tamiflu.
You may also be interested in...
Leavitt Defends Bush’s Flu Pandemic Preparedness Plan To Senate
HHS will subsidize about 25% of states’ antiviral costs, leading senators to question whether preparedness in some states could suffer.
Roche Increases Tamiflu Manufacturing Capacity In Time For 2006 Season
President Bush will request $7.1 bil. for pandemic avian flu preparedness, $1 bil. of which will be earmarked for antiviral stockpiling.
“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.